PNPLA3 and hepatocellular carcinoma: Furthermore, higher prevalence for HCC development and poorer prognosis was reported to be associated with PNPLA3 polymorphism in viral and nonviral chronic liver diseases (Khlaiphuengsin et al, 2015).